GENE ONLINE|News &
Opinion
Blog

PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
Keytruda Wins Big in China, Now Approved for Esophageal Squamous Cell Carcinomas
2020-06-26
ASCO 2020: Immunotherapy Gives Hope to Women with Placental Cancer
2020-06-01
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Weekly in Asia|Oct-1
2019-10-14
Weekly in Asia 20190609-0615
2019-06-21
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
Next Gen IO update – early phase clinical trials of anti-TIGIT/LAG3 antibodies
2018-11-08
1 2
LATEST
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
EVENT
Scroll to Top